全球腫瘤消融市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

腫瘤消融市場預計將從 2025 年的 27.3 億美元成長到 2034 年的 89.8 億美元，2026 年至 2034 年的複合年成長率為 14.12%。

隨著微創癌症治療技術的進步，全球腫瘤消融市場正在顯著擴張。射頻消融、微波消融和冷凍消融等技術在腫瘤治療的應用日益廣泛，顯著縮短了患者的復原時間。醫院正將這些技術作為傳統手術的安全替代方案。

成長要素包括癌症發生率上升、技術創新和醫療費用支出增加。早期診斷項目和影像技術的改進提高了手術成功率。在醫療保健體系完善的國家，需求特別強勁。

預計未來成長將主要由機器人輔助消融術和人工智慧引導影像診斷技術的融合所驅動。新興國家腫瘤中心的擴張也將進一步提振需求。對先進醫療設備的持續研發和監管核准可望加速全球市場的擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球腫瘤消融市場：依技術分類

• 市場分析、洞察與預測
• 射頻消融術
• 微波消融術
• 冷凍消融術
• 不可逆電穿孔消融術
• 高強度聚焦超音波
• 其他

第5章 全球腫瘤消融市場：依治療方法

• 市場分析、洞察與預測
• 外科消融術
• 腹腔鏡消融術
• 經皮術

第6章 全球腫瘤消融市場：依應用領域分類

• 市場分析、洞察與預測
• 腎癌
• 肝癌
• 乳癌
• 肺癌
• 攝護腺癌
• 其他

第7章 全球腫瘤消融市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Medtronic
  • Boston Scientific Corp
  • Johnson & Johnson Service Inc.（Ethicon, Inc.）
  • AngioDynamics
  • Bioventus Inc.（Misonix Inc.）
  • EDAP TMS
  • Chongqing Haifu Medical Technology Co.Ltd
  • Mermaid Medical
  • HealthTronicsInc
  • HS Hospital Service SPA

The Tumor Ablation Market size is expected to reach USD 8.98 Billion in 2034 from USD 2.73 Billion (2025) growing at a CAGR of 14.12% during 2026-2034.

The Global Tumor Ablation Market has expanded significantly with advancements in minimally invasive cancer treatments. Technologies such as radiofrequency, microwave, and cryoablation are increasingly used to treat tumors with reduced recovery times. Hospitals are adopting these procedures as safer alternatives to traditional surgery.

Growth drivers include rising cancer incidence rates, technological innovation, and increasing healthcare expenditure. Early diagnosis programs and improved imaging techniques have enhanced procedural success rates. Demand is particularly strong in developed healthcare systems.

Future growth is expected through integration of robotic-assisted ablation and AI-guided imaging. Expanding oncology centers in emerging economies will further support demand. Continuous research and regulatory approvals for advanced devices are anticipated to accelerate market expansion globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Irreversible Electroporation Ablation
• HIFU
• Other

By Treatment

• Surgical Ablation
• Laparoscopic Ablation
• Percutaneous Ablation

By Application

• Kidney Cancer
• Liver Cancer
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Other

COMPANIES PROFILED

• Medtronic, Boston Scientific Corp, Johnson Johnson Service Inc Ethicon, Inc, AngioDynamics, Bioventus Inc Misonix Inc, EDAP TMS, Chongqing Haifu Medical Technology Co, Ltd, Mermaid Medical, HealthTronics, Inc, HS Hospital Service SpA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TUMOR ABLATION MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Radiofrequency Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Microwave Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cryoablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Irreversible Electroporation Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. HIFU Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TUMOR ABLATION MARKET: BY TREATMENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Treatment
• 5.2. Surgical Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Laparoscopic Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Percutaneous Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TUMOR ABLATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Kidney Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Liver Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TUMOR ABLATION MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Treatment
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Treatment
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Treatment
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Treatment
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Treatment
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TUMOR ABLATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Boston Scientific Corp
  • 9.2.3 Johnson & Johnson Service Inc. (Ethicon, Inc.)
  • 9.2.4 AngioDynamics
  • 9.2.5 Bioventus Inc. (Misonix Inc.)
  • 9.2.6 EDAP TMS
  • 9.2.7 Chongqing Haifu Medical Technology Co.Ltd
  • 9.2.8 Mermaid Medical
  • 9.2.9 HealthTronicsInc
  • 9.2.10 H.S. Hospital Service S.P.A